RDLCX
Price
$9.34
Change
+$0.10 (+1.08%)
Updated
Dec 20 closing price
VIGIX
Price
$214.82
Change
+$2.24 (+1.05%)
Updated
Dec 20 closing price
Ad is loading...

RDLCX vs VIGIX

Header iconRDLCX vs VIGIX Comparison
Open Charts RDLCX vs VIGIXBanner chart's image
Columbia Disciplined Growth C
Price$9.34
Change+$0.10 (+1.08%)
VolumeN/A
CapitalizationN/A
Vanguard Growth Index Institutional
Price$214.82
Change+$2.24 (+1.05%)
VolumeN/A
CapitalizationN/A
RDLCX vs VIGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RDLCX vs. VIGIX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RDLCX is a Buy and VIGIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VIGIX has more cash in the bank: 282B vs. RDLCX (317M). VIGIX pays higher dividends than RDLCX: VIGIX (0.53) vs RDLCX (0.00). RDLCX was incepted earlier than VIGIX: RDLCX (18 years) vs VIGIX (27 years). RDLCX is a more actively managed with annual turnover of: 71.00 vs. VIGIX (5.00). RDLCX has a lower initial minimum investment than VIGIX: RDLCX (2000) vs VIGIX (5000000). VIGIX annual gain was more profitable for investors over the last year : 34.37 vs. RDLCX (16.17). VIGIX return over 5 years is better than : 129.76 vs. RDLCX (8.23).
RDLCXVIGIXRDLCX / VIGIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years27 years-
Gain YTD16.16934.27247%
Front LoadN/AN/A-
Min. Initial Investment200050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets317M282B0%
Annual Yield % from dividends0.000.53-
Returns for 1 year16.1734.3747%
Returns for 3 years-1.1632.77-4%
Returns for 5 years8.23129.766%
Returns for 10 years7.73298.583%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCL238.437.67
+3.32%
Royal Caribbean Group
ATUS2.640.08
+3.13%
Altice USA
CCCC3.950.11
+2.73%
C4 Therapeutics
PFSI101.661.56
+1.56%
PennyMac Financial Services
ELEV0.58-0.05
-7.30%
Elevation Oncology